About this trial
This phase II trial studies how well respiratory muscle training before surgery works in preventing lung complications after surgery in patients with stage I-IIIB lung cancer. Patients with lung cancer who choose to undergo surgical resection often have complications after surgery such as pneumonia, unplanned intubations, difficulty breathing and reduced physical functioning, and increased medical costs and a reduced quality of life. Improving pre-surgical pulmonary health through respiratory muscle training may improve respiratory muscle strength, response to surgery, and quality of life after surgery in patients with lung cancer.
Eligibility criteria
Qualifiers
Documented stage I-IIIb lung cancer or is undergoing surgery for diagnosis
Participant is able to speak, read, and comprehend English
Participant must be undergoing or is anticipated to either video-assisted thoracic surgery (VATS or robotic surgery) or laparoscopic surgery for curative intent lung resection
Patients with or without neoadjuvant chemoradiotherapy (CRT) prior to surgery will be included
Disqualifiers
Documented ischemic heart disease; congestive heart failure or; significant cardiac arrhythmias that would exclude them from having surgery
Overall medical frailty (clinician discretion) or ECOG > 2
Pregnant or nursing female participants
Unwilling or unable to follow protocol requirements
Trial design
Treatments tested in this trial
- Best Practice
- Laparoscopic Surgery
- Quality-of-Life Assessment
- Questionnaire Administration
- Respiratory Muscle Training Device
- Video-Assisted Thoracic Surgery
Treatment groups
Locations
1Sponsors and collaborators
Roswell Park Cancer Institute
Lead sponsor
National Cancer Institute (NCI)
Collaborator